No association between TAU haplotype and Alzheimer's disease in population or clinic based series or in familial disease

[1]  M. Bullido,et al.  A polymorphism in the tau gene associated with risk for Alzheimer's disease , 2000, Neuroscience Letters.

[2]  B. Winblad,et al.  Tau gene polymorphisms and apolipoprotein E ε4 may interact to increase risk for Alzheimer’s disease , 1999, Neuroscience Letters.

[3]  R. Sulkava,et al.  Genetic association of α2‐macroglobulin with Alzheimer's disease in a Finnish elderly population , 1999, Annals of neurology.

[4]  M. Gold,et al.  No genetic association between polymorphisms in the Tau gene and Alzheimer's disease in clinic or population based samples , 1999, Neuroscience Letters.

[5]  I Litvan,et al.  Association of an extended haplotype in the tau gene with progressive supranuclear palsy. , 1999, Human molecular genetics.

[6]  M. Owen,et al.  No association between the alpha-2 macroglobulin I1000V polymorphism and Alzheimer's disease , 1999, Neuroscience Letters.

[7]  M. Owen,et al.  A full genome scan for late onset Alzheimer's disease , 1999 .

[8]  C. Duijn,et al.  High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands. , 1999, American journal of human genetics.

[9]  Ronald C. Petersen,et al.  Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 , 1998, Nature.

[10]  John Hardy,et al.  Amyloid, the presenilins and Alzheimer's disease , 1997, Trends in Neurosciences.

[11]  L. Thal,et al.  Genetic evidence for the involvement of τ in progressive supranuclear palsy , 1997, Annals of neurology.

[12]  H. Braak,et al.  Age, neurofibrillary changes, Aβ-amyloid and the onset of Alzheimer's disease , 1996, Neuroscience Letters.

[13]  John Hardy,et al.  Single-day apolipoprotein E genotyping , 1994, Journal of Neuroscience Methods.